XMRV low level of expression in human cells delays superinfection interference and allows proviral copies to accumulate

Virology

Volumn 456-457, Issue 1, 2014, Pages 28-38

  Laurent, Fanny ^a,b   Tchénio, Thierry ^a   Buckle, Malcolm ^a   Hazan, Uriel ^a   Bury Moné, Stéphanie ^a  

^a Ecole Normale Superieure de Cachan   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Human cells; Provirus accumulation; Species barrier; Viral expression; Viral interference; XMRV

Indexed keywords

COMPLEMENTARY DNA; TRANSACTIVATOR PROTEIN; VIRUS DNA;

ARTICLE; CONTROLLED STUDY; DNA SYNTHESIS; FITNESS; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLECULAR CLONING; NONHUMAN; PATHOGENESIS; PHYLOGENY; PLASMID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROVIRUS; QUANTITATIVE ANALYSIS; RETROVIRUS; SUPERINFECTION; TRANSGENE; VIRUS EXPRESSION; VIRUS INFECTION; VIRUS INTERFERENCE; VIRUS PARTICLE; VIRUS REPLICATION; VIRUS TRANSCRIPTION; XENOTROPIC MULV RELATED VIRUS; XENOTROPIC MULV RELATED VIRUS INFECTION;

HUMAN CELLS; PROVIRUS ACCUMULATION; SPECIES BARRIER; VIRAL EXPRESSION; VIRAL INTERFERENCE; XMRV;

ANIMALS; CELL LINE; GAMMARETROVIRUS; GENE EXPRESSION; HUMANS; MICE; PROMOTER REGIONS, GENETIC; PROVIRUSES; TRANSCRIPTION, GENETIC; TRANSDUCTION, GENETIC; VIRUS REPLICATION;

EID: 84897869299     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2014.03.006     Document Type: Article

References (55)

1. Achong B.G., Trumper P.A., Giovanella B.C. C-type virus particles in human tumours transplanted into nude mice. Br. J. Cancer 1976, 34:203-206.
2. Anisimova M., Gascuel O. Approximate likelihood-ratio test for branches: a fast, accurate, and powerful alternative. Syst. Biol. 2006, 55:539-552.
3. Bardy P., Conneally E., Emerman J.T., Lansdorp P.M., Goss G., Humphries R.K., Eaves C.J. Isolation and analysis of different subpopulations of normal human breast epithelial cells after their infection with a retroviral vector encoding a cell surface marker. Breast Cancer Res. Treat. 1997, 44:153-165.
4. Castresana J. Selection of conserved blocks from multiple alignments for their use in phylogenetic analysis. Mol. Biol. Evol. 2000, 17:540-552.
5. Cervantes-Garcia D., Rojas-Martinez A., Camerini D. An XMRV derived retroviral vector as a tool for gene transfer. Virol. J. 2011, 8:284.
6. Chaipan C., Dilley K.A., Paprotka T., Delviks-Frankenberry K.A., Venkatachari N.J., Hu W.S., Pathak V.K. Severe restriction of xenotropic murine leukemia virus-related virus replication and spread in cultured human peripheral blood mononuclear cells. J. Virol. 2011, 85:4888-4897.
7. Conneally E., Bardy P., Eaves C.J., Thomas T., Chappel S., Shpall E.J., Humphries R.K. Rapid and efficient selection of human hematopoietic cells expressing murine heat-stable antigen as an indicator of retroviral-mediated gene transfer. Blood 1996, 87:456-464.
8. D'Souza V., Summers M.F. Structural basis for packaging the dimeric genome of Moloney murine leukaemia virus. Nature 2004, 431:586-590.
9. Delviks-Frankenberry K., Paprotka T., Cingoz O., Wildt S., Hu W.S., Coffin J.M., Pathak V.K. Generation of multiple replication-competent retroviruses through recombination between PreXMRV-1 and PreXMRV-2. J. Virol. 2013, 87:11525-11537.
10. Dereeper A., Guignon V., Blanc G., Audic S., Buffet S., Chevenet F., Dufayard J.F., Guindon S., Lefort V., Lescot M., Claverie J.M., Gascuel O. Phylogeny.fr: robust phylogenetic analysis for the non-specialist. Nucleic Acids Res. 2008, 36:W465-469.
11. Dong B., Silverman R.H. Androgen stimulates transcription and replication of xenotropic murine leukemia virus-related virus. J. Virol. 2010, 84:1648-1651.
12. Dong B., Kim S., Hong S., Das Gupta J., Malathi K., Klein E.A., Ganem D., Derisi J.L., Chow S.A., Silverman R.H. An infectious retrovirus susceptible to an IFN antiviral pathway from human prostate tumors. Proc. Nat. Acad. Sci. U.S.A. 2007, 104:1655-1660.
13. Dong B., Silverman R.H., Kandel E.S. A natural human retrovirus efficiently complements vectors based on murine leukemia virus. PLoS One 2008, 3:e3144.
14. Duverger A., Jones J., May J., Bibollet-Ruche F., Wagner F.A., Cron R.Q., Kutsch O. Determinants of the establishment of human immunodeficiency virus type 1 latency. J. Virol. 2009, 83:3078-3093.
15. Edgar R.C. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res. 2004, 32:1792-1797.
16. Groom H.C., Yap M.W., Galao R.P., Neil S.J., Bishop K.N. Susceptibility of xenotropic murine leukemia virus-related virus (XMRV) to retroviral restriction factors. Proc. Nat. Acad. Sci. U.S.A. 2010, 107:5166-5171.
17. Hawley R.G., Lieu F.H., Fong A.Z., Hawley T.S. Versatile retroviral vectors for potential use in gene therapy. Gene Ther. 1994, 1:136-138.
18. Hempel H.A., Burns K.H., De Marzo A.M., Sfanos K.S. Infection of xenotransplanted human cell lines by murine retroviruses: a lesson brought back to light by XMRV. Front. Oncol. 2013, 3:156.
19. Hibbert C.S., Mirro J., Rein A. mRNA molecules containing murine leukemia virus packaging signals are encapsidated as dimers. J. Virol. 2004, 78:10927-10938.
20. Hoggan M.D., O'Neill R.R., Kozak C.A. Nonecotropic murine leukemia viruses in BALB/c and NFS/N mice: characterization of the BALB/c Bxv-1 provirus and the single NFS endogenous xenotrope. J. Virol. 1986, 60:980-986.
21. Hou Y., Zhang H., Miranda L., Lin S. Serious overestimation in quantitative PCR by circular (supercoiled) plasmid standard: microalgal pcna as the model gene. PLoS One 2010, 5:e9545.
22. Huson D.H., Scornavacca C. Dendroscope 3: an interactive tool for rooted phylogenetic trees and networks. Syst. Biol. 2012, 61:1061-1067.
23. Jern P., Stoye J.P., Coffin J.M. Role of APOBEC3 in genetic diversity among endogenous murine leukemia viruses. PLoS Genet. 2007, 3:2014-2022.
24. Josefsson L., Palmer S., Faria N.R., Lemey P., Casazza J., Ambrozak D., Kearney M., Shao W., Kottilil S., Sneller M., Mellors J., Coffin J.M., Maldarelli F. Single cell analysis of lymph node tissue from HIV-1 infected patients reveals that the majority of CD4+ T-cells contain one HIV-1 DNA molecule. PLoS Pathog. 2013, 9:e1003432.
25. Jung Y.T., Wu T., Kozak C.A. Novel host range and cytopathic variant of ecotropic Friend murine leukemia virus. J. Virol. 2004, 78:12189-12197.
26. Keshet E., Temin H.M. Cell killing by spleen necrosis virus is correlated with a transient accumulation of spleen necrosis virus DNA. J. Virol. 1979, 31:376-388.
27. Knouf E.C., Metzger M.J., Mitchell P.S., Arroyo J.D., Chevillet J.R., Tewari M., Miller A.D. Multiple integrated copies and high-level production of the human retrovirus XMRV (Xenotropic Murine Leukemia Virus-Related Virus) from 22Rv1 Prostate Carcinoma Cells. J. Virol. 2009, 83:7353-7356.
28. Manic G., Maurin-Marlin A., Galluzzi L., Subra F., Mouscadet J.F., Bury-Mone S. 3' self-inactivating long terminal repeat inserts for the modulation of transgene expression from lentiviral vectors. Hum. Gene Ther. Methods 2012, 23:84-97.
29. Manic G., Maurin-Marlin A., Laurent F., Vitale I., Thierry S., Delelis O., Dessen P., Vincendeau M., Leib-Mosch C., Hazan U., Mouscadet J.F., Bury-Mone S. Impact of the Ku complex on HIV-1 expression and latency. PLoS One 2013, 8:e69691.
30. McAllister R.M., Nicolson M., Gardner M.B., Rongey R.W., Rasheed S., Sarma P.S., Huebner R.J., Hatanaka M., Oroszlan S., Gilden R.V., Kabigting A., Vernon L. C-type virus released from cultured human rhabdomyosarcoma cells. Nat. New Biol. 1972, 235:3-6.
31. Mullins J.I., Chen C.S., Hoover E.A. Disease-specific and tissue-specific production of unintegrated feline leukaemia virus variant DNA in feline AIDS. Nature 1986, 319:333-336.
32. Nash K.L., Lever A.M. Green fluorescent protein: green cells do not always indicate gene expression. Gene Ther. 2004, 11:882-883.
33. Nitta T., Lee S., Ha D., Arias M., Kozak C.A., Fan H. Moloney murine leukemia virus glyco-gag facilitates xenotropic murine leukemia virus-related virus replication through human APOBEC3-independent mechanisms. Retrovirology 2012, 9:58.
34. Odawara T., Oshima M., Doi K., Iwamoto A., Yoshikura H. Threshold number of provirus copies required per cell for efficient virus production and interference in moloney murine leukemia virus-infected NIH 3T3 cells. J. Virol. 1998, 72:5414-5424.
35. Ory D.S., Neugeboren B.A., Mulligan R.C. A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes. Proc. Nat. Acad. Sci. U.S.A. 1996, 93:11400-11406.
36. Paprotka T., Delviks-Frankenberry K.A., Cingoz O., Martinez A., Kung H.J., Tepper C.G., Hu W.S., Fivash M.J., Coffin J.M., Pathak V.K. Recombinant origin of the retrovirus XMRV. Science (New York, N.Y.) 2011, 333:97-101.
37. Pauza C.D., Galindo J.E., Richman D.D. Reinfection results in accumulation of unintegrated viral DNA in cytopathic and persistent human immunodeficiency virus type 1 infection of CEM cells. J. Exp. Med. 1990, 172:1035-1042.
38. Pear W.S., Miller J.P., Xu L., Pui J.C., Soffer B., Quackenbush R.C., Pendergast A.M., Bronson R., Aster J.C., Scott M.L., Baltimore D. Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr/abl-transduced bone marrow. Blood 1998, 92:3780-3792.
39. Pearson R., Kim Y.K., Hokello J., Lassen K., Friedman J., Tyagi M., Karn J. Epigenetic silencing of human immunodeficiency virus (HIV) transcription by formation of restrictive chromatin structures at the viral long terminal repeat drives the progressive entry of HIV into latency. J. Virol. 2008, 82:12291-12303.
40. Rainey G.J., Coffin J.M. Evolution of broad host range in retroviruses leads to cell death mediated by highly cytopathic variants. J. Virol. 2006, 80:562-570.
41. Rodriguez J.J., Goff S.P. Xenotropic murine leukemia virus-related virus establishes an efficient spreading infection and exhibits enhanced transcriptional activity in prostate carcinoma cells. J. Virol. 2010, 84:2556-2562.
42. Rulli S.J., Hibbert C.S., Mirro J., Pederson T., Biswal S., Rein A. Selective and nonselective packaging of cellular RNAs in retrovirus particles. J. Virol. 2007, 81:6623-6631.
43. Sakakibara S., Sakakibara K., Tosato G. NF-kappaB activation stimulates transcription and replication of retrovirus XMRV in human B-lineage and prostate carcinoma cells. J. Virol. 2011, 85:3179-3186.
44. Sfanos K.S., Aloia A.L., Hicks J.L., Esopi D.M., Steranka J.P., Shao W., Sanchez-Martinez S., Yegnasubramanian S., Burns K.H., Rein A., De Marzo A.M. Identification of replication competent murine gammaretroviruses in commonly used prostate cancer cell lines. PLoS One 2011, 6:e20874.
45. Stocking C., Kollek R., Bergholz U., Ostertag W. Long terminal repeat sequences impart hematopoietic transformation properties to the myeloproliferative sarcoma virus. Proc. Nat. Acad. Sci. U.S.A. 1985, 82:5746-5750.
46. Sturzel C.M., Palesch D., Khalid M., Wissing S., Fischer N., Munch J. Utilization of replication-competent XMRV reporter-viruses reveals severe viral restriction in primary human cells. PLoS One 2013, 8:e74427.
47. Suzuki T., Yanagihara K., Yoshida K., Seido T., Kuga N. Infectious Murine Type-C Viruses Released from Human Cancer Cells Transplated into Nude Mice. Gann=Gan 1977, 68:99-106.
48. Temin H.M. Mechanisms of cell killing/cytopathic effects by nonhuman retroviruses. Rev. Infect. Dis. 1988, 10:399-405.
49. Todaro G.J., Arnstein P., Parks W.P., Lennette E.H., Huebner R.J. A type-C virus in human rhabdomyosarcoma cells after inoculation into NIH Swiss mice treated with antithymocyte serum. Proc. Nat. Acad. Sci. U.S.A. 1973, 70:859-862.
50. Tomonaga K., Coffin J.M. Structures of endogenous nonecotropic murine leukemia virus (MLV) long terminal repeats in wild mice: implication for evolution of MLVs. J. Virol. 1999, 73:4327-4340.
51. Urisman A., Molinaro R.J., Fischer N., Plummer S.J., Casey G., Klein E.A., Malathi K., Magi-Galluzzi C., Tubbs R.R., Ganem D., Silverman R.H., DeRisi J.L. Identification of a novel gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant. PLoS Pathog. 2006, 2:e25.
52. Weller S.K., Joy A.E., Temin H.M. Correlation between cell killing and massive second-round superinfection by members of some subgroups of avian leukosis virus. J. Virol. 1980, 33:494-506.
53. Whelan J.T., Kellogg A., Shewchuk B.M., Hewan-Lowe K., Bertrand F.E. Notch-1 signaling is lost in prostate adenocarcinoma and promotes PTEN gene expression. J. Cell. Biochem. 2009, 107:992-1001.
54. Yoshimura F.K., Wang T., Nanua S. Mink cell focus-forming murine leukemia virus killing of mink cells involves apoptosis and superinfection. J. Virol. 2001, 75:6007-6015.
55. Zhang Y.A., Maitra A., Hsieh J.T., Rudin C.M., Peacock C.D., Karikari C., Brekken R.A., Stastny V., Gao B., Girard L., Wistuba I., Frenkel E., Minna J.D., Gazdar A.F. Frequent detection of infectious xenotropic murine leukemia virus (XMLV) in human cultures established from mouse xenografts. Cancer Biol. Ther. 2011, 12:617-628.